Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (146)

2024

  1. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

2023

  1. Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

    Antibiotics, Vol. 12, Núm. 2

  2. Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579

  3. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

  4. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

2022

  1. Clinical and Epidemiologic Characteristics of a Cohort of HIV-Infected Mother-Infant Pairs During 21 Years

    Journal of Acquired Immune Deficiency Syndromes, Vol. 91, Núm. 5, pp. 479-484

  2. Congenital cytomegalovirus infection in newborns born to HIV-infected mothers

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 557-561

  3. Integrase inhibitors in children and adolescents: Clinical use and resistance

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 10, pp. 2784-2792

  4. Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial

    Frontiers in Pediatrics, Vol. 10

  5. Pediatric Chagas disease in the non-endemic area of Madrid: A fifteen-year review (2004–2018)

    PLoS Neglected Tropical Diseases, Vol. 16, Núm. 2

  6. Pregnancy Outcomes Among Perinatally HIV-Infected Women in Spain

    Journal of acquired immune deficiency syndromes (1999), Vol. 91, Núm. 4, pp. 373-380

  7. Prevalence of psychological symptoms and associated risk factors in a Spanish sample of HIV-positive youth compared to uninfected peers

    Anales de Pediatria, Vol. 96, Núm. 3, pp. 203-212

  8. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  9. SARS-CoV-2 Infection in Children and Adolescents Living With HIV in Madrid

    The Pediatric infectious disease journal, Vol. 41, Núm. 10, pp. 824-826

2021

  1. A systematic review of magnetic resonance imaging studies in perinatally HIV-infected individuals

    AIDS Reviews, Vol. 23, Núm. 4, pp. 167-185

  2. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood

    Medicine, Vol. 100, Núm. 15, pp. e25403

  3. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

  4. Mortality in Perinatally HIV-infected Adolescents after Transition to Adult Care in Spain

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 4, pp. 347-350

  5. Pneumococcal osteomyelitis of the rib in a vaccinated infant; an exceptional case

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 6, pp. 311-312

  6. Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1886-1892